Matt Kalaycio

Cleveland Clinic - Taussig Cancer ...Cleveland, Ohio - 44195 The Cleveland Clinic FoundationCleveland, Ohio - 44195 (216-444-2520) Cleveland ClinicCleveland, Ohio - 44195 (216-445-9243) |
- CLINICAL TRIALS 3
- CONDITIONS7
- INTERVENTIONS5
- SINCE2008

Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) Acute Myeloid Leukemia (AML)
January 2009 - February 2013

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)
January 2009 - June 2018

Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
November 2008 - November 2011
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Placebo
Lenalidomide
Cytarabine
Idarubicin
Bendamustine Plus Alemtuzumab



